webinars

Events Calendar

Flat View
See by year
Monthly View
See by month
Categories
See by categories

Anniversary: FDA Safety and Innovation Act

Wednesday, July 09, 2014

The Food and Drug Administration Safety and Innovation Act has a provision (section 904) that authorizes the Board to convene a working group to develop best practices for making information on prescription drug container labels accessible to people who are blind or visually impaired. The best practices were completed in July 2013.

Signed by: Barack H. Obama

Date signed: July 9, 2012

Public Law: 112-144

U.S. Code: 29 U.S.C. 792 note

Back